NTRK3 and breast carcinoma: We first investigated the cytokine levels in TrkC + murine 4T1 breast cancer model13 that has been treated with IYIY-I2-BODIPY, YIYI-I2-BODIPY or I2-BODIPY, the latter two as controls.